A switch from an anti-inflammatory to a pro-inflammatory phenotype has been found in myeloid cells treated with CSF-1R inhibitors that limit brain metastasis or intracranial growth [25, 53], and similar findings have been reported in glioblastoma [28]. This evidence concerns the gene CSF1R and glioblastoma.